Skip to main content
The Journal of Infectious Diseases logoLink to The Journal of Infectious Diseases
. 2021 May 19;224(12):2064–2072. doi: 10.1093/infdis/jiab264

The Effect of Diabetes and Prediabetes on Mycobacterium tuberculosis Transmission to Close Contacts

María B Arriaga 1,2,3,#, Michael S Rocha 2,4,#, Betânia M F Nogueira 2,3,4,#, Vanessa Nascimento 2,4,5,#, Mariana Araújo-Pereira 1,2,3, Alexandra B Souza 6,7, Alice M S Andrade 1,2, Alysson G Costa 6,7, Adriano Gomes-Silva 8, Elisangela C Silva 9, Marina C Figueiredo 10, Megan M Turner 10, Betina Durovni 11, José R Lapa-e-Silva 9, Afrânio L Kritski 9, Solange Cavalcante 8,11, Valeria C Rolla 8, Marcelo Cordeiro-Santos 6,7,12, Timothy R Sterling 10,#, Bruno B Andrade 1,2,3,4,5,13,#,, for the RePORT Brazil Consortium
PMCID: PMC8672762  PMID: 34008010

Abstract

Background

It is unknown whether dysglycemia is associated with Mycobacterium tuberculosis transmission.

Methods

We assessed epidemiological and clinical characteristics of patients with culture-confirmed pulmonary tuberculosis and their close contacts, enrolled in a multicenter prospective cohort in Brazil. Contacts were investigated at baseline and 6 months after enrollment. QuantiFERON positivity at baseline and conversion (from negative to positive at month 6) were compared between subgroups of contacts according to glycemic status of persons with tuberculosis (PWTB) as diabetes mellitus (DM) or prediabetes. Multivariable mixed-effects logistic regression models were performed to test independent associations with baseline QuantiFERON positive and QuantiFERON conversion.

Results

There were 592 PWTB (153 DM, 141 prediabetes, 211 normoglycemic) and 1784 contacts, of whom 658 were QuantiFERON-positive at baseline and 106 converters. Multivariable analyses demonstrated that tuberculosis-prediabetes cases, acid-fast bacilli-positive, pulmonary cavities, and living with someone who smoked were independently associated with QuantiFERON positive in contacts at baseline. DM, persistent cough, acid-fast bacilli-positive, and pulmonary cavities in tuberculosis source cases were associated with QuantiFERON conversion.

Conclusions

Contacts of persons with pulmonary tuberculosis and dysglycemia were at increased risk of being QuantiFERON positive at baseline or month 6. Increased focus on such close contacts could improve tuberculosis control.

Keywords: diabetes, prediabetes, quantiFERON, interferon-γ releasing assay, Mycobacterium tuberculosis


Diabetes is a risk factor for tuberculosis, but its association with Mycobacterium tuberculosis transmission is unclear. We performed a prospective study demonstrating that close contacts of pulmonary tuberculosis patients with dysglycemia had an increased risk of M. tuberculosis infection.


Understanding factors associated with Mycobacterium tuberculosis transmission is an important component for tuberculosis control. M. tuberculosis is transmitted via aerosols generated by people with active pulmonary tuberculosis, through speaking, coughing, or sneezing [1]. Individuals with more severe pulmonary tuberculosis may emit higher numbers of infectious droplet nuclei. Vigorous and persistent cough, as well as cavitary lung lesions, may increase the emission of infectious droplets [2]. Other drivers of M. tuberculosis transmission include biological characteristics of M. tuberculosis [3], the number of contacts, the proximity and duration of contact, delays in tuberculosis diagnosis in the source case, and environmental factors such as closed indoor spaces with low air circulation and no ultraviolet light [2]. Other factors are associated with higher risk of developing tuberculosis, such as human immunodeficiency virus (HIV) infection, diabetes mellitus (DM), smoking, alcohol abuse, and malnutrition [2, 3]. Although DM is associated with an increased risk of developing active disease once infected with M. tuberculosis [4], the effect of DM on M. tuberculosis transmission has not been evaluated.

Previous studies have found that persons with DM (PWDM) and tuberculosis more frequently present with extensive or cavitary pulmonary tuberculosis than normoglycemic patients [5]. Furthermore, persons with tuberculosis (PWTB) with DM exhibit a higher bacillary load in sputum [6, 7], more persistent cough [8], and delayed mycobacterial clearance compared to persons without DM [7, 8]. Although DM has the potential to increase M. tuberculosis transmission, to our knowledge no studies have directly investigated this hypothesis. We therefore investigated whether contacts of persons with pulmonary tuberculosis and dysglycemia were at increased risk of M. tuberculosis infection compared to contacts of normoglycemic PWTB.

METHODS

Ethics Statement

The study was conducted according to the principles of the Declaration of Helsinki. The RePORT-Brazil protocol was approved by the institutional review boards at each study site and at Vanderbilt University Medical Center. Participation in RePORT-Brazil was voluntary and written informed consent was obtained from all participants.

Study Design

This was a multicenter prospective observational cohort study of individuals ≥18 years old with culture-confirmed pulmonary tuberculosis and their close contacts. Description of RePORT sites and data collection is presented in Supplementary Methods and in [9].

For this protocol, close contacts were defined as having ≥4 hours of contact/week with the tuberculosis index case at any time in the previous 6 months [10]. Contacts identified who agreed to participate in the study were evaluated at 2 visits: baseline and 6 months after enrollment. They were also contacted by phone at months 12, 18, and 24 to see if they developed active tuberculosis. At the baseline visit QuantiFERON (QTF) testing was performed, and at month 6 a repeat QTF was performed if the initial QTF result was negative. Individuals whose QTF result was indeterminate (at either the baseline or month 6 visit) or who did not have a second QTF performed at month 6 (if negative at baseline) were excluded from the analysis. For tuberculosis index cases for whom close contacts were excluded from this study, data from the index case were not included in the statistical analyses.

Study Definitions

In PWTB, DM was defined according to baseline hemoglobin A1c (HbA1c), following American Diabetes Association guidelines [11]. Patients were classified as having DM (HbA1c ≥ 6.5%), prediabetes (PDM; HbA1c = 5.7%–6.4%), or normoglycemia (HbA1c < 5.7%). HbA1c ≥ 5.7% was classified as dysglycemia. For tuberculosis close contacts, DM status was obtained by self-report or by HbA1c when available. To investigate M. tuberculosis transmission, we considered a positive result of the first (baseline) or second QTF (month 6) test an indicator of M. tuberculosis infection.

Data Analysis

Categorical variables were presented as proportions and compared using a 2-sided Pearson χ 2 test (with Yates correction) or Fisher 2-tailed test. Continuous variables were presented as median and interquartile range and compared using the Mann-Whitney U (between 2 groups) or Kruskal-Wallis test (between ≥2 groups). To evaluate independent associations between clinical characteristics of pulmonary tuberculosis index cases and presence of diabetes and/or PDM, we used unadjusted and multivariable-adjusted binomial logistic regression models. Variables were selected using the stepwise method (Wald) with backward selection criteria. We additionally assessed associations between clinical characteristics of PWTB and contacts and QTF results (positive at baseline or QTF conversion, compared to contacts who were QTF negative at both baseline and month 6) using unadjusted and multivariable-adjusted mixed-effects logistic regression models [12]. The “tuberculosis case” variable was included as the random effect term to address clustering of tuberculosis cases with more than one contact. Parameters with P values ≤.2 in univariate analyses were included in multivariable models. For the analysis of clinical characteristics of PWTB and contact QTF result, we also used bootstrapping to estimate a bias-corrected coefficient, addressing potential bias due to small sample size [13]. Over 1000 bootstrap iterations, we sampled with replacement from the data and estimated coefficients within the bootstrap sample; the unit of resampling was “the contacts from the same tuberculosis case.” The distribution of those coefficient estimates over the 1000 bootstrap iterations were used to estimate the mean and 95% confidence intervals (CI) of the bias-corrected coefficient estimates. P values <.05 were considered statistically significant. Statistical analyses were performed using SPSS 24.0 (IBM Statistics), Graphpad Prism 6.0 (GraphPad Software), and R 3.1.0 (R Foundation).

RESULTS

Characteristics of Study Participants

RePORT-Brazil enrolled 1038 patients with culture-positive pulmonary tuberculosis during the study period, of whom 592 had close contacts who enrolled in the study. Of the 1038, 643 (62%) had dysglycemia at baseline (Figure 1). Additional information is provided in Supplementary Table 1. Among all dysglycemic PWTB, 61.1% had PDM (n = 393, 37.9% of all PWTB) and 38.9% had DM (n = 250, 24.1% of all PWTB). Details are in Supplementary Table 2 and Supplementary Table 3. Among PWTB, 446 (43%) did not have a close contact enrolled into our study. Of the 592 PWTB who reported contacts, an average of 3 contacts per PWTB were enrolled. PWTB who had contacts were stratified according to glycemic status at the time of diagnosis: tuberculosis-dysglycemia (n = 381, 64.4%) and tuberculosis-normoglycemia (n = 211, 35.6%) (Figure 1).

Figure 1.

Figure 1.

Study flow chart. The main objective of the study was to compare incident tuberculosis (TB) infection among contacts from pulmonary tuberculosis patients with or without dysglycemia. Data were obtained from 1038 individuals diagnosed with culture-confirmed pulmonary tuberculosis enrolled into the RePORT Brazil study protocol. Of those, 592 (57%) had close contacts (average of 3 contacts per tuberculosis index case) who enrolled and were included in the analyses. During the clinical and laboratory evaluation (hemoglobin A1c levels) of the tuberculosis index cases, 141 had prediabetes (PDM), 153 had type-2 diabetes (DM), and 211 were normoglycemic. In 609 contacts of 198 tuberculosis-normoglycemic patients and 1186 contacts of 294 tuberculosis-dysglycemic patients the first QuantiFERON (QTF) test was performed. The close contacts enrolled of each tuberculosis index case were evaluated, and screening for Mycobacterium tuberculosis infection was performed with clinical and radiographic examination as well as with QTF testing. Those who had negative QTF result at baseline underwent repeat QTF testing at 6 months to assess for QTF conversion. For the present study, individuals whose QTF result was indeterminate (ind; first or second QTF) or those who did not have a second QTF test performed at month 6 of follow-up were excluded from the analysis.

There were 609 contacts of 211 normoglycemic PWTB and 1186 close contacts of 381 dysglycemic PWTB. There were 47 contacts with indeterminate QTF results either at baseline or at the month 6 visit, who were excluded. There were an additional 175 contacts considered lost to follow-up because they missed the second QTF test; they were also excluded. The sample size with which all further analyses were performed was 1573 close tuberculosis contacts: 537 close contacts of 198 normoglycemic PWTB and 1036 contacts of 294 dysglycemic PWTB (DM = 153 and PDM = 141) (Figure 1).

Characteristics of Tuberculosis Close Contacts

Tuberculosis close contacts were next grouped according to the glycemic status of their tuberculosis index case. Contacts of normoglycemic PWTB more frequently had DM (P = .011) and reported illicit drug use than contacts of PWTB with diabetes or PDM (Figure 2A). Other detailed comparisons among the subgroups of tuberculosis close contacts are shown in Supplementary Table 3. The Sankey diagram shown in Figure 2B describes the QTF results, the number of tuberculosis close contacts with QTF conversion from negative to positive, and active tuberculosis incidence. Close contacts of normoglycemic PWTB more frequently exhibited a positive QTF at the baseline visit than contacts from PWDM or PDM (Figure 2C). The different groups of tuberculosis close contacts could be distinguished by frequency of QTF conversion (Figure 2D). The highest tuberculosis incidence values were found in QTF-positive individuals who were close contacts of tuberculosis index cases with PDM or normoglycemia (0.44 and 0.38 persons-years, respectively).

Figure 2.

Figure 2.

Characteristics of contacts of patients with active tuberculosis (TB) stratified by glycemic status. A, Characteristics of the close contacts of pulmonary tuberculosis patients stratified according to the presence of diabetes (DM) or prediabetes (PDM) were compared with those from patients with normoglycemia using the Fisher exact test (additional comparisons are displayed in Supplementary Table 3). B, Sankey diagram shows number of close contacts of pulmonary tuberculosis patients stratified based on QuantiFERON (QTF) test result. Number of individuals who developed incident tuberculosis during the follow-up is also highlighted (blue font) in each indicated subgroup. C, Frequency of tuberculosis contacts who tested positive in the first QTF result (prevalent latent tuberculosis infection) stratified based on the glycemic status of the tuberculosis index case. D, Frequency of tuberculosis contacts who were QTF negative in the first examination and tested positive in the second evaluation (QTF conversion, incident tuberculosis infection), stratified based on the glycemic status of the PWTB. C and D, Data were compared using the Fisher exact test. A, C, and D, P values were adjusted for clustering by index case. Abbreviation: CI, confidence interval.

The final set of analyses stratified tuberculosis close contacts into 3 groups according to the final QTF test result: (1) those who tested positive at the baseline visit (QTF positive, n = 658), (2) those who tested negative at both baseline and month 6 visit (QTF negative, n = 809), and (3) those who tested negative at the baseline visit and positive at the month-6 visit (QTF conversion, n = 106). Comparisons of characteristics of these study subgroups of tuberculosis contacts are described in Supplementary Table 4. The frequency of smokers was significantly higher in the positive QTF group (29.5%) versus negative QTF (22.9%) (P = .001). Individuals with QTF conversion were more frequently contacts of PWTB with DM, whereas those with a negative QTF more commonly were contacts of prediabetic PWTB (Figure 3A). QTF-positive participants were generally contacts of normoglycemic PWTB (Figure 3A). Additional analyses revealed that HIV infection was more frequently detected in tuberculosis index cases who had QTF-negative contacts (P < .001; Figure 3B). Of note, tuberculosis index cases who had acid-fast bacilli (AFB)-positive sputum smears and exhibited cavitary lung lesions were more likely to have contacts who were QTF positive or converted the QTF result at month 6 visit (P < .001; Figure 3B). Moreover, QTF-positive contacts were on average older than those who were QTF negative and those who experienced QTF conversion (P < .001; Figure 3C). The subgroup of tuberculosis contacts with QTF conversion more frequently reported smoking. No participant from this latter group had DM.

Figure 3.

Figure 3.

Factors associated with tuberculosis infection in contacts of pulmonary tuberculosis patients with diabetes and prediabetes. A, Characteristics of the close contacts of pulmonary tuberculosis patients stratified according to the QTF test result were compared using the Fisher exact test (additional comparisons are displayed in Supplementary Table 3). B, Frequency of indicated characteristics of the pulmonary tuberculosis index cases stratified based on the QTF results of the contacts was compared using the Pearson χ 2 test. C, Left, scatter plot shows distribution of age (median and interquartile range) among the subgroups of contacts of persons with tuberculosis based on the QTF result. Data were compared using the Kruskal-Wallis test with Dunn multiple comparisons ad hoc test. The difference in median age values between the groups of positive QTF and of QTF conversion was statistically significant. Right, frequency of close tuberculosis contacts with the indicated characteristics was compared between the subgroups based on the QTF result was compared using the Pearson χ 2 . D, A multivariable mixed-effects logistic regression with a random effect per “tuberculosis case” (to decrease the possible selection bias, because 1 “tuberculosis case” can have more than 1 contact, with different QTF results) was used to test association between indicated characteristics of pulmonary tuberculosis index patients or of the tuberculosis close contacts and positivity of the baseline QTF test or conversion of the QTF result in tuberculosis contacts. Variables included in the adjusted model exhibited univariate P values≤.2 (see Supplementary Table 4 for details). A, B, and C, P values were adjusted for clustering by index case. Passive smoking was defined as living with someone who smokes. Persistent cough was defined as patients who reported cough at the initial evaluation (month 0) and also at the month 2 visit. Abbreviations: AFB, acid-fast bacilli; CI, confidence interval; DM, diabetes; HIV, human immunodeficiency virus; NA, not applicable; nd, not detected; PDM, prediabetes; QTF, QuantiFERON; TB, tuberculosis.

A multivariable mixed-effects logistic regression with a random effect per “tuberculosis case” tested associations between characteristics of PWTB, or of tuberculosis contacts and positivity of the QTF test at baseline or conversion of the QTF in tuberculosis contacts. The results demonstrated that PDM (adjusted odds ratio [aOR], 1.54; 95% CI, 1.25–1.65; P = .002), passive smoking (aOR, 1.44; 95% CI, 1.25–1.82; P = .003), AFB smear positive (aOR, 1.54; 95% CI, 1.19–1.99; P = .001), cavitary lung lesions (aOR, 1.68; 95% CI, 1.32–2.13; P < .001), and age (aOR, 1.01; 95% CI, 1.01–1.03; P < .001) were important characteristics of PWTB associated with positive QTF in contacts, independent of other confounding factors (Figure 3D, left). Interestingly, this model also revealed characteristics of tuberculosis index cases that were independently related with QTF conversion in contacts, such as DM (aOR, 1.21; CI, 1.01–1.98; P = .046), persistent cough (aOR, 1.67; 95% CI, 1.00–2.45; P = .0049) AFB positive (aOR, 1.99; 95% CI, 1.17–3.40; P = .012), and cavitary lung lesions (aOR, 1.94; 95% CI, 1.23–3.05; P < .001) (Figure 3D, right). When evaluating the same model using 1000 bootstrap iterations, the association between DM and QTF conversion was slightly increased, yet similar to the original model, indicating relatively low bias due to small sample size (OR, 1.77; 95% CI, 1.05–2.98; P = .031) (Figure 4).

Figure 4.

Figure 4.

Factors associated with QTF conversion in contacts of pulmonary tuberculosis patients. A multivariable mixed-effects logistic regression with a random effect per “tuberculosis case.” Estimates are bias-corrected based on 1000 bootstrap iterations to account for the small sample size. Estimates (in terms of odds ratios) reflect associations between indicated characteristics of pulmonary tuberculosis index patients or of the tuberculosis close contacts and conversion of the QTF result (incident tuberculosis infection) in tuberculosis contacts. Variables included in the adjusted model exhibited univariate P values ≤.2 (see Supplementary Table 4 for details). Persistent cough was defined as patients who reported cough in the initial evaluation interview (month 0) and also in the month 2 visit. Abbreviations: AFB, acid-fast bacilli; CI, confidence interval; QTF, QuantiFERON; TB, tuberculosis.

Discussion

Identifying whether DM affects M. tuberculosis transmission is important to guide tuberculosis control strategies. Previous studies have found that dysglycemia in tuberculosis contacts can make them more susceptible to infection [4, 14–16] but to date it had not been investigated whether tuberculosis-DM increases the risk of contacts acquiring M. tuberculosis infection. In the current study, 62% of PWTB presented with dysglycemia (PDM or DM) and 37.9% had DM. This prevalence is higher than recently reported in Ethiopia [17], Peru [18], and India [19], as well as in a previous study of our group, from a smaller subpopulation from Northeastern Brazil [20]. In the previous study, we observed a 63.1% prevalence of dysglycemia, which is comparable to the present study, but the DM prevalence was lower (25%). This difference could be explained by the heterogeneity of the population in the country. The current cohort is larger and includes individuals from different regions of the country (5 sites of RePORT Brazil, located in 3 states), while the previous cohort included individuals from just one state. That said, the cohort in the present study is more representative of Brazilian PWTB [21]. In spite of the different frequency of PWDM, the present work had findings consistent with the previous one, such as higher body mass index (BMI) and higher prevalence of cough and weight loss in patients with dysglycemia, particularly in PWDM [20].

Tuberculosis-DM patients exhibited similar characteristics to those in a large cohort of 709 000 Brazilians with tuberculosis from 2007 to 2014: mostly men, mean age >40 years, self-reported black or pardo, and low frequency of HIV-infection [22, 23].

Tuberculosis-DM patients more frequently reported smoking and alcohol consumption, which are shared risk factors for both diseases [3, 24, 25]. This corroborates the relationship described in populations from Peru, Mexico, and South Africa [6, 18], where PWTB with DM and PDM were older and had an increased BMI compared to normoglycemic PWTB.

There were 1573 contacts followed up in this study. Only 1% (n = 16) of the close contacts had a confirmed diagnosis of tuberculosis at the baseline visit, while 42% (n = 658) were diagnosed with latent tuberculosis infection (LTBI). The findings are comparable with what has been reported in low to middle-income countries, including Brazil, where the prevalence of active tuberculosis in contacts was 1.4%, while the prevalence of LTBI was 51.5% [26].

Only 81 (5%) tuberculosis contacts were diagnosed with DM. This prevalence is 12 times lower than that reported in household tuberculosis contacts from India [27], but could be an underestimate, because HbA1c was not routinely measured in all contacts and many DM diagnoses were self-reported. In our study, these individuals were primarily contacts of normoglycemic PWTB.

Among those who had a negative QTF at baseline, 106 (6.7%) converted to positive QTF at the 6-month visit. An Ethiopian study [28] using QTF-tuberculosis Gold to follow tuberculosis household contacts for 1 year demonstrated that nearly half of negative QTF individuals at the first visit became positive after 12 months and for this reason the authors suggested that repeated screening of QTF-negative contacts may be needed for early diagnosis of LTBI. Because the second QTF in our study was carried out once, at 6 months after baseline, this may explain the lower conversion rate.

Regarding factors that could potentially increase M. tuberculosis transmission, tuberculosis-DM index cases had a significantly higher frequency of positive AFB sputum smears, consistent with previous publications [3, 29]. However, there was no significant difference in presence of cavities between the DM, PDM, and normoglycemic tuberculosis index cases subgroups. Although this was not expected based on the prior literature, it has been described before in a Brazilian retrospective cohort study [8]. Similarly, persistent cough was unexpectedly more common in the normoglycemic PWTB group. A possible explanation for both findings could be an earlier diagnosis of tuberculosis in Brazilian PWDM, self-reported response, other conditions that can stimulate or inhibit cough (use of medications, smoking, or neuroperipheral lesions among others) may be related to this result. In fact, most patients were newly diagnosed (156, 62.4%) and were not taking anti-DM drugs. Brazil has a decentralized public health care system and PWDM, who are already in the system and followed by family medicine teams, may have easier access to healthcare to evaluate symptoms. Furthermore, tuberculosis-DM patients had significantly more symptoms such as weight loss and fatigue, which is associated with earlier health care-seeking behavior and diagnosis of tuberculosis [20].

When assessing PWTB-related factors associated with baseline positive QTF in contacts, DM was not found to be a significant factor, whereas normal HbA1c, positive AFB, and presence of cavities on X-ray were associated with a significantly increased risk of LTBI. While these findings have clinical importance, a positive QTF at baseline may not be the most accurate measure for the purpose of this study, as the positivity can be related to a previous exposure. In this scenario, QTF conversion within 6 months of follow-up may be a better measure of recent exposure and infection. After adjusting for confounders, the following index case-related factors significantly increased the risk of QTF conversion: DM, persistent cough, AFB positive, and presence of cavitary lung lesions. Contacts with a tuberculosis-DM index case were 1.21 times more likely to be infected with M. tuberculosis compared to contacts of a normoglycemic tuberculosis index case. These findings confirm our hypothesis that tuberculosis-DM increased M. tuberculosis transmission and corroborates previous studies that reported persistent cough, AFB positivity, and presence of cavitation on chest X-ray increase M. tuberculosis transmission risk [2, 30]. The differing results regarding tuberculosis index case diabetes and prediabetes, and baseline QTF and QTF conversion, require further evaluation in additional cohorts.

After adjusting for confounders, the only individual characteristics of tuberculosis contacts significantly associated with an increased risk of QTF conversion was increased age. Other factors previously found to increase the risk of acquiring tuberculosis (DM, HIV, smoking, and alcohol use) were not confirmed in this study [31].

The present study had some limitations. Dysglycemia was investigated by means of HbA1c levels; we did not perform fasting glucose levels or oral glucose tolerance tests. Although glycated hemoglobin levels have been reliably used to estimate dysglycemia in several studies, it is possible that the final numbers of DM and PDM would have differed if additional laboratory assessments had been used. In this prospective cohort, additional measurements of HbA1c were not performed at other study time points. Thus, it was not possible to investigate whether transient versus persistent dysglycemia over the course of antituberculosis treatment had differential impact on M. tuberculosis transmission to close contacts. The tuberculosis close contacts were not systematically screened for DM using HbA1c in all study sites, and DM was recorded based only on self-report. The use of anti-DM drugs was not uniformly recorded, and it is possible that patients with dysglycemia receiving medication to lower the glucose levels may have exhibited a differential impact on M. tuberculosis transmission. Finally, we did not have data on whether the pulmonary lesions in the tuberculosis index case were upper versus lower lobe; this information could help determine why tuberculosis index cases with DM were less likely to have cavitary disease.

The present study adds important knowledge to the field by demonstrating that dysglycemic PWTB were at higher risk of transmitting M. tuberculosis to close contacts in a well-characterized, large, multicenter cohort in Brazil. In addition, the follow-up of contacts of PWTB with the highest probability of transmitting M. tuberculosis can optimize strategies focused on controlling the disease [32]. Actions focused on disease control among contacts [33, 34] is one of the main pillars for reducing tuberculosis incidence.

Supplementary Data

Supplementary materials are available at The Journal of Infectious Diseases online. Consisting of data provided by the authors to benefit the reader, the posted materials are not copyedited and are the sole responsibility of the authors, so questions or comments should be addressed to the corresponding author.

jiab264_suppl_Supplementary_Materials

Notes

Acknowledgments. The authors thank the study participants. A special thanks to Dr. Lauren Peetluk (Vanderbilt University Medical Center, Nashville, USA) for assistance with the description of the statistical models and to Mrs. Elze Leite (FIOCRUZ, Salvador, Brazil), Ms. Hilary Vansell (Vanderbilt University Medical Center, Nashville, USA), Mr. Eduardo Gama (FIOCRUZ, Rio de Janeiro, Brazil) and Mr. Elcimar Junior (Fundação Medicina Tropical Doutor Heitor Vieira Dourado, Manaus, Brazil), for administrative and logistical support.

Disclaimer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Financial support. This work was supported by the Conselho Nacional de Desenvolvimento Científico e Tecnológico and Departamento de Ciência e Tecnologia, Secretaria de Ciência e Tecnologia, Ministério da Saúde, Brazil (grant number 25029.000507/2013-07 to V. C. R.); the National Institutes of Allergy and Infectious Diseases (grant number U01 AI069923); and the Intramural Research Programs of the Fundação Oswaldo Cruz and the Fundação José Silveira. B. B. A. was supported by the National Institutes of Health (grant number U01 AI115940). B. B. A., A. L. K., and J. R. L. S. are senior scientists at the Conselho Nacional de Desenvolvimento Científico e Tecnológico. M. B. A. received a scholarship from Fundação de Amparo à Pesquisa do Estado da Bahia. M. A. P. received a research fellowship from the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.

Potential conflicts of interest. All authors: No reported conflicts of interest. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.

References

  • 1. Houben RM, Dodd PJ. The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling. PLoS Med 2016; 13:e1002152. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Mathema B, Andrews JR, Cohen T, et al. Drivers of tuberculosis transmission. J Infect Dis 2017; 216:644–53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Lönnroth K, Jaramillo E, Williams BG, Dye C, Raviglione M. Drivers of tuberculosis epidemics: the role of risk factors and social determinants. Soc Sci Med 2009; 68:2240–6. [DOI] [PubMed] [Google Scholar]
  • 4. Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med 2008; 5:e152. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Pizzol D, Di Gennaro F, Chhaganlal KD, et al. Tuberculosis and diabetes: current state and future perspectives. Trop Med Int Health 2016; 21:694–702. [DOI] [PubMed] [Google Scholar]
  • 6. Restrepo BI, Fisher-Hoch SP, Crespo JG, et al. ; Nuevo Santander Tuberculosis Trackers . Type 2 diabetes and tuberculosis in a dynamic bi-national border population. Epidemiol Infect 2007; 135:483–91. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Singla R, Khan N, Al-Sharif N, Ai-Sayegh MO, Shaikh MA, Osman MM. Influence of diabetes on manifestations and treatment outcome of pulmonary TB patients. Int J Tuberc Lung Dis 2006; 10:74–9. [PubMed] [Google Scholar]
  • 8. Gil-Santana L, Almeida-Junior JL, Oliveira CA, et al. Diabetes is associated with worse clinical presentation in tuberculosis patients from Brazil: a retrospective cohort study. PLoS One 2016; 11:e0146876. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. RePORT-Brazil. Regional Prospective Observational Research for Tuberculosis. https://reportbrazil.org. Accessed 8 August 2020.
  • 10. Loredo C, Cailleaux-Cezar M, Efron A, de Mello FC, Conde MB. Yield of close contact tracing using two different programmatic approaches from tuberculosis index cases: a retrospective quasi-experimental study. BMC Pulm Med 2014; 14:133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. American Diabetes Association. Glycemic targets: standards of medical care in diabetes. Diabetes Care 2020; 42:S187–S93. [DOI] [PubMed] [Google Scholar]
  • 12. Gelman A, Hill J.. Data analysis using regression and multilevel/hierarchical models. New York: Cambridge University Press, 2006. [Google Scholar]
  • 13. Hastie T, Tibshirani R, Friedman J.. The elements of statistical learning: data mining, inference, and prediction. Springer series in statistics. 2nd ed. New York: Springer, 2009. [Google Scholar]
  • 14. Al-Rifai RH, Pearson F, Critchley JA, Abu-Raddad LJ. Association between diabetes mellitus and active tuberculosis: A systematic review and meta-analysis. PLoS One 2017; 12:e0187967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Hayashi S, Chandramohan D. Risk of active tuberculosis among people with diabetes mellitus: systematic review and meta-analysis. Trop Med Int Health 2018; 23:1058–70. [DOI] [PubMed] [Google Scholar]
  • 16. Hoa NB, Phuc PD, Hien NT, et al. Prevalence and associated factors of diabetes mellitus among tuberculosis patients in Hanoi, Vietnam. BMC Infect Dis 2018; 18:603. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Workneh MH, Bjune GA, Yimer SA. Prevalence and associated factors of diabetes mellitus among tuberculosis patients in south-eastern Amhara region, Ethiopia: a cross sectional study. PLoS One 2016; 11:e0147621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Calderon RI, Arriaga MB, Lopez K, et al. High prevalence and heterogeneity of dysglycemia in patients with tuberculosis from Peru: a prospective cohort study. BMC Infect Dis 2019; 19:799. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Mave V, Meshram S, Lokhande R, et al. Prevalence of dysglycemia and clinical presentation of pulmonary tuberculosis in western India. Int J Tuberc Lung Dis 2017; 21:1280–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Almeida-Junior JL, Gil-Santana L, Oliveira CA, et al. Glucose metabolism disorder is associated with pulmonary tuberculosis in individuals with respiratory symptoms from Brazil. PLoS One 2016; 11:e0153590. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Arriaga MB, Amorim G, Queiroz ATL, et al. ; RePORT Brazil Consortium . Novel stepwise approach to assess representativeness of a large multicenter observational cohort of tuberculosis patients: The example of RePORT Brazil. Int J Infect Dis 2021; 103:110–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Evangelista M, Maia R, Toledo JP, Abreu RG, Barreira D. Tuberculosis associated with diabetes mellitus by age group in Brazil: a retrospective cohort study, 2007–2014. Braz J Infect Dis 2020; 24:130–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Julius H, Basu D, Ricci E, et al. The burden of metabolic diseases amongst HIV positive patients on HAART attending The Johannesburg Hospital. Curr HIV Res 2011; 9:247–52. [DOI] [PubMed] [Google Scholar]
  • 24. Soh AZ, Chee CBE, Wang YT, Yuan JM, Koh WP. Alcohol drinking and cigarette smoking in relation to risk of active tuberculosis: prospective cohort study. BMJ Open Respir Res 2017; 4:e000247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Yu M, Xu CX, Zhu HH, et al. Associations of cigarette smoking and alcohol consumption with metabolic syndrome in a male Chinese population: a cross-sectional study. J Epidemiol 2014; 24:361–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Fox GJ, Barry SE, Britton WJ, Marks GB. Contact investigation for tuberculosis: a systematic review and meta-analysis. Eur Respir J 2013; 41:140–56. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Shivakumar SVBY, Chandrasekaran P, Kumar AMV, et al. Diabetes and pre-diabetes among household contacts of tuberculosis patients in India: is it time to screen them all? Int J Tuberc Lung Dis 2018; 22:686–94. [DOI] [PubMed] [Google Scholar]
  • 28. Belay M, Legesse M, Dagne D, et al. QuantiFERON-TB Gold in-tube test conversions and reversions among tuberculosis patients and their household contacts in Addis Ababa: a one year follow-up study. BMC Infect Dis 2014; 14:654. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Park SW, Shin JW, Kim JY, et al. The effect of diabetic control status on the clinical features of pulmonary tuberculosis. Eur J Clin Microbiol Infect Dis 2012; 31:1305–10. [DOI] [PubMed] [Google Scholar]
  • 30. Turner RD, Bothamley GH. Cough and the transmission of tuberculosis. J Infect Dis 2015; 211:1367–72. [DOI] [PubMed] [Google Scholar]
  • 31. Rajan JV, Ferrazoli L, Waldman EA, et al. Diabetes increases the risk of recent-transmission tuberculosis in household contacts in São Paulo, Brazil. Int J Tuberc Lung Dis 2017; 21:916–21. [DOI] [PubMed] [Google Scholar]
  • 32. World Health Organization (WHO). Latent tuberculosis infection: updated and consolidated guidelines for programmatic management. Geneva, Switzerland: WHO, 2018. [PubMed] [Google Scholar]
  • 33. World Health Organization (WHO). Framework for implementing the “end TB strategy” in the African Region 2016–2020. Geneva, Switzerland: WHO, 2017. [Google Scholar]
  • 34. Dye C, Glaziou P, Floyd K, Raviglione M. Prospects for tuberculosis elimination. Annu Rev Public Health 2013; 34:271–86. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

jiab264_suppl_Supplementary_Materials

Articles from The Journal of Infectious Diseases are provided here courtesy of Oxford University Press

RESOURCES